Kalimin 60 N KALYMIN Pyridostigmine Bromide 60mg 100 tablets Калимин Н

KALYMIN INDICATIONS: 

Myasthenia gravis;

myasthenic syndrome (Lambert-Eaton syndrome) as part of combination therapy with guanidine.

APPLICATION: 

For oral administration. The dose and duration of treatment are determined by the doctor depending on the course of the disease and the patient's response to treatment.

Myasthenia gravis

For symptomatic treatment of myasthenia gravis in adults, it is recommended to use
1‒3 tablets of Kalimin® 60 H 3‒4 times daily (180‒720 mg daily).

Contraindication:

Kalimin® 60 N is contraindicated for use in patients with a history of hypersensitivity to the constituents of the drug, in the mechanical obstruction of the digestive tract and urinary tract; diseases associated with elevated tone of the bronchial muscles (eg, bronchial asthma and spastic bronchitis), inflammation of the eye (iritis), during breastfeeding.